AR081220A1 - Uso de teriflunomida para el tratamiento de la atrofia cerebral - Google Patents
Uso de teriflunomida para el tratamiento de la atrofia cerebralInfo
- Publication number
- AR081220A1 AR081220A1 ARP110101770A ARP110101770A AR081220A1 AR 081220 A1 AR081220 A1 AR 081220A1 AR P110101770 A ARP110101770 A AR P110101770A AR P110101770 A ARP110101770 A AR P110101770A AR 081220 A1 AR081220 A1 AR 081220A1
- Authority
- AR
- Argentina
- Prior art keywords
- teriflunomide
- treatment
- brain atrophy
- atrophy
- brain
- Prior art date
Links
- UTNUDOFZCWSZMS-YFHOEESVSA-N teriflunomide Chemical compound C\C(O)=C(/C#N)C(=O)NC1=CC=C(C(F)(F)F)C=C1 UTNUDOFZCWSZMS-YFHOEESVSA-N 0.000 title abstract 2
- 229960000331 teriflunomide Drugs 0.000 title abstract 2
- 208000024806 Brain atrophy Diseases 0.000 title 1
- 206010008096 Cerebral atrophy Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de teriflunomida para tratar la atrofia cerebral en un paciente que lo necesita.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34849410P | 2010-05-26 | 2010-05-26 | |
| US38937510P | 2010-10-04 | 2010-10-04 | |
| US39140010P | 2010-10-08 | 2010-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR081220A1 true AR081220A1 (es) | 2012-07-04 |
Family
ID=44211940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101770A AR081220A1 (es) | 2010-05-26 | 2011-05-24 | Uso de teriflunomida para el tratamiento de la atrofia cerebral |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR081220A1 (es) |
| TW (1) | TW201208674A (es) |
| UY (1) | UY33411A (es) |
| WO (1) | WO2011150014A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012061062A1 (en) * | 2010-10-25 | 2012-05-10 | Sanofi-Aventis U.S. Llc | Use of teriflunomide for improving motor function |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5268382A (en) | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
| GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
-
2011
- 2011-05-24 AR ARP110101770A patent/AR081220A1/es unknown
- 2011-05-25 WO PCT/US2011/037847 patent/WO2011150014A1/en not_active Ceased
- 2011-05-25 TW TW100118220A patent/TW201208674A/zh unknown
- 2011-05-26 UY UY0001033411A patent/UY33411A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011150014A1 (en) | 2011-12-01 |
| TW201208674A (en) | 2012-03-01 |
| UY33411A (es) | 2011-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP24031979A (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
| ECSP14017269A (es) | Compuestos para tratar la atrofia muscular espinal | |
| CU20120161A7 (es) | 5-fluoro-1h-pirazolopiridinas sustituidas | |
| MX358514B (es) | Compuestos para tratar la atrofia muscular espinal. | |
| AR089993A1 (es) | Macrociclos peptidomimeticos | |
| UY34165A (es) | ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?. | |
| MX2015003140A (es) | Formulaciones de enzalutamida. | |
| BRPI1013698A2 (pt) | métodos para tratamento com o uso de terapia de combinação | |
| CL2012003385A1 (es) | Tratamiento para la incontinencia. | |
| PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
| IL229474B (en) | Cannabinoids for use in the treatment of neuropathic pain | |
| BR112012029746A2 (pt) | composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| MX365321B (es) | Métodos para el tratamiento de neutropenia mediante agonistas retinoides. | |
| CO7160080A2 (es) | Composiciones lipídicas de racecadotrillo | |
| BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
| GT201400242A (es) | "nuevos compuestos de pirazol" | |
| FI20115165A0 (fi) | Terapeuttisia ja diagnostisia menetelmiä | |
| MX2015011775A (es) | Uso de levocetirizina y montelukast en el tratamiento de anafilaxis. | |
| BR112014000670A2 (pt) | uso de compostos oligossacarídeo para a prevenção e tratamento de cicatrizes patológicas | |
| AR082436A1 (es) | Uso de teriflunomida para tratar la esclerosis multiple | |
| AR081220A1 (es) | Uso de teriflunomida para el tratamiento de la atrofia cerebral | |
| IN2014KN01772A (es) | ||
| ECSP17021138A (es) | Compuestos de dipeptidil-cetoamida y su uso para el tratamiento y/o la prevención de la acumulación de grasa | |
| BR112014002806A2 (pt) | uso cosmético oral e processo cosmético para tratar e/ou prevenir odor corporal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |